Melmed S (2015) Pituitary tumors. Endocrinol Metab Clin North Am 44:1–9. https://doi.org/10.1016/j.ecl.2014.11.004

Article  PubMed Central  PubMed  Google Scholar 

Sheplan Olsen LJ, Robles Irizarry L, Chao ST et al (2012) Radiotherapy for prolactin-secreting pituitary tumors. Pituitary 15:135–145. https://doi.org/10.1007/s11102-011-0348-6

Article  PubMed  Google Scholar 

Lloyd RV, Osamura RY, Kloppel G, Rosai J (2017) WHO classification of tumours of endocrine organs: WHO classification of tumours. International Agency for Research on Cancer, Lyon

Google Scholar 

Lopes MBS (2020) World health ozganization 2017 classification of pituitary tumors. Endocrinol Metab Clin North Am 49:375–386. https://doi.org/10.1016/j.ecl.2020.05.001

Article  PubMed  Google Scholar 

Asa SL, Casar-Borota O, Chanson P et al (2017) From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr Relat Cancer 24:C5–C8. https://doi.org/10.1530/ERC-17-0004

Article  CAS  PubMed  Google Scholar 

Colao A, Savastano S (2011) Medical treatment of prolactinomas. Nat Rev Endocrinol 7:267–278. https://doi.org/10.1038/nrendo.2011.37

Article  CAS  PubMed  Google Scholar 

Krokker L, Nyírő G, Reiniger L et al (2019) Differentially expressed miRNAs influence metabolic processes in pituitary oncocytoma. Neurochem Res 44:2360–2371. https://doi.org/10.1007/s11064-019-02789-2

Article  CAS  PubMed Central  PubMed  Google Scholar 

Välimäki N, Schalin-Jäntti C, Karppinen A et al (2019) Genetic and epigenetic characterization of growth hormone-secreting pituitary tumors. Mol Cancer Res 17:2432–2443. https://doi.org/10.1158/1541-7786.MCR-19-0434

Article  PubMed  Google Scholar 

van den Brand AD, Rubinstein E, van den Berg M, van Duursen MBM (2019) GH3 and RC-4BC cell lines are not suitable as in vitro models to study prolactin modulation and AHR responsiveness in rat pituitary. Mol Cell Endocrinol 496:110520. https://doi.org/10.1016/j.mce.2019.110520

Article  CAS  PubMed  Google Scholar 

Lee I, Ajay SS, Yook JI et al (2009) New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites. Genome Res 19:1175–1183. https://doi.org/10.1101/gr.089367.108

Article  CAS  PubMed Central  PubMed  Google Scholar 

Fabian MR, Sonenberg N (2012) The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 19:586–593. https://doi.org/10.1038/nsmb.2296

Article  CAS  PubMed  Google Scholar 

Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297. https://doi.org/10.1016/s0092-8674(04)00045-5

Article  CAS  PubMed  Google Scholar 

Treiber T, Treiber N, Meister G (2019) Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol 20:5–20. https://doi.org/10.1038/s41580-018-0059-1

Article  CAS  PubMed  Google Scholar 

Qadir MI, Faheem A (2017) miRNA: a diagnostic and therapeutic tool for pancreatic cancer. Crit Rev Eukaryot Gene Expr 27:197–204. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2017019494

Article  PubMed  Google Scholar 

Tutar Y (2014) Editorial (thematic issue: “miRNA and cancer; computational and experimental approaches”). Curr Pharm Biotechnol 15:429–429. https://doi.org/10.2174/138920101505140828161335

Article  CAS  PubMed  Google Scholar 

Feng Y, Mao Z, Wang X et al (2018) microRNAs and target genes in pituitary adenomas. Horm Metab Res 50:179–192. https://doi.org/10.1055/s-0043-123763

Article  CAS  PubMed  Google Scholar 

D’Angelo D, Palmieri D, Mussnich P et al (2012) Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. J Clin Endocrinol Metab 97:1128–1138

Article  Google Scholar 

Ru Y, Kechris KJ, Tabakoff B et al (2014) The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations. Nucleic Acids Res 42:e133–e133. https://doi.org/10.1093/nar/gku631

Article  CAS  PubMed Central  PubMed  Google Scholar 

Tsai P-J, Lai Y-H, Manne RK et al (2022) Akt: a key transducer in cancer. J Biomed Sci 29:76. https://doi.org/10.1186/s12929-022-00860-9

Article  PubMed Central  PubMed  Google Scholar 

He Y, Sun MM, Zhang GG et al (2021) Targeting PI3K/Akt signal transduction for cancer therapy. Signal Transduct Target Ther 6:425. https://doi.org/10.1038/s41392-021-00828-5

Article  CAS  PubMed Central  PubMed  Google Scholar 

Barrett T, Wilhite SE, Ledoux P et al (2012) NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res 41:D991–D995. https://doi.org/10.1093/nar/gks1193

Article  CAS  PubMed Central  PubMed  Google Scholar 

Roche M, Wierinckx A, Croze S et al (2015) Deregulation of miR-183 and KIAA0101 in aggressive and malignant pituitary tumors. Front Med. https://doi.org/10.3389/fmed.2015.00054

Article  Google Scholar 

Wierinckx A, Roche M, Raverot G et al (2011) Integrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumors: integrated genomic profiling in PRL pituitary tumors. Brain Pathol. https://doi.org/10.1111/j.1750-3639.2011.00476.x

Article  PubMed Central  PubMed  Google Scholar 

Xu T, Su N, Liu L et al (2018) miRBaseConverter: an R/Bioconductor package for converting and retrieving miRNA name, accession, sequence and family information in different versions of miRBase. BMC Bioinform 19:514. https://doi.org/10.1186/s12859-018-2531-5

Article  CAS  Google Scholar 

Agarwal V, Bell GW, Nam J-W, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4:e05005. https://doi.org/10.7554/eLife.05005

Article  PubMed Central  PubMed  Google Scholar 

Rehmsmeier M, Steffen P, Höchsmann M, Giegerich R (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10:1507–1517. https://doi.org/10.1261/rna.5248604

Article  CAS  PubMed Central  PubMed  Google Scholar 

Wu L, Chen J, Ding C et al (2015) MicroRNA-137 contributes to dampened tumorigenesis in human gastric cancer by targeting AKT2. PLoS ONE 10:e0130124. https://doi.org/10.1371/journal.pone.0130124

Article  CAS  PubMed Central  PubMed  Google Scholar 

Melmed S, Kaiser UB, Lopes MB et al (2022) Clinical biology of the pituitary adenoma. Endocr Rev. https://doi.org/10.1210/endrev/bnac010

Article  PubMed Central  PubMed  Google Scholar 

Salehi F, Agur A, Scheithauer BW et al (2009) KI-67 in pituitary neoplasms. Neurosurgery 65:429–437. https://doi.org/10.1227/01.NEU.0000349930.66434.82

Article  PubMed  Google Scholar 

Jordan S, Lidhar K, Korbonits M et al (2000) Cyclin D and cyclin E expression in normal and adenomatous pituitary. Eur J Endocrinol 143:R1–R6. https://doi.org/10.1530/eje.0.143r001

Article  CAS  PubMed  Google Scholar 

Ilie MD, Vasiljevic A, Raverot G, Bertolino P (2019) The microenvironment of pituitary tumors—biological and therapeutic implications. Cancers 11:1605. https://doi.org/10.3390/cancers11101605

Article  CAS  PubMed Central  PubMed  Google Scholar 

Karginov FV, Hannon GJ (2013) Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. Genes Dev 27(14):1624–1632. https://doi.org/10.1101/gad.215939.113

Article  CAS  PubMed Central  PubMed  Google Scholar 

Xiao Z, Wang Z, Hu B et al (2019) MiR-1299 promotes the synthesis and secretion of prolactin by inhibiting FOXO1 expression in drug-resistant prolactinomas. Biochem Biophys Res Commun 520:79–85. https://doi.org/10.1016/j.bbrc.2019.09.070

Article  CAS  PubMed  Google Scholar 

Glezer A, Bronstein MD (2014) Prolactinoma. Arq Bras Endocrinol Amp Metabol 58:118–123. https://doi.org/10.1590/0004-2730000002961

Article  Google Scholar 

Tang C, Sun R, Wen G et al (2019) Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively. Cell Death Dis 10:335. https://doi.org/10.1038/s41419-019-1526-0

Article  PubMed Central  PubMed  Google Scholar 

Mishra S, Yadav T, Rani V (2016) Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol 98:12–23. https://doi.org/10.1016/j.critrevonc.2015.10.003

Article  PubMed  Google Scholar 

Armand-Labit V, Pradines A (2017) Circulating cell-free microRNAs as clinical cancer biomarkers. Biomol Concepts 8:61–81. https://doi.org/10.1515/bmc-2017-0002

Article  CAS  PubMed  Google Scholar